New rules will help clarify Medicare Part D billing for Zostavax (zoster vaccine)
January 2008
New rules will help clarify Medicare Part D billing for Zostavax (zoster vaccine).
Zostavax shots are used in patients aged 60 and over to reduce the risk of shingles or some types of pain associated with shingles. Some pharmacies offer Zostavax shots to patients in the pharmacy.
Zostavax is covered under Medicare Part D drug plans...not Part B like flu and pneumococcal vaccines.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote